Details for the $62.4b acquisition of Shire PLC by Takeda Pharmaceutical Co. Ltd. have begun to crystalize as critical dates for European Commission and shareholder approval for the historic event are set. Japan’s biggest overseas M&A acquisition ever, the Shire takeover brings with it the specter of possible future divestments as a means of mitigating company debt.
Find out more about the mega-deal, details about the funding structure of this transaction, and possible future repercussions of the merger in this illuminating article from Scrip.
Find out more about the mega-deal, details about the funding structure of this transaction, and possible future repercussions of the merger in this illuminating article from Scrip.
